Header Logo

Connection

Jeffrey Swanson to Comorbidity

This is a "connection" page, showing publications Jeffrey Swanson has written about Comorbidity.
Connection Strength

0.430
  1. Bareis N, Edlund M, Ringeisen H, Guyer H, Dixon LB, Olfson M, Smith TE, Chwastiak L, Monroe-DeVita M, Swartz M, Swanson J, Sinclair Hancq E, Geiger P, Kreski NT, Stroup TS. Characterizing Schizophrenia Spectrum Disorders: Results of the U.S. Mental and Substance Use Disorders Prevalence Study. Psychiatr Serv. 2025 Jan 01; 76(1):2-12.
    View in: PubMed
    Score: 0.174
  2. Swanson JW, Sampson NA, Petukhova MV, Zaslavsky AM, Appelbaum PS, Swartz MS, Kessler RC. Guns, Impulsive Angry Behavior, and Mental Disorders: Results from the National Comorbidity Survey Replication (NCS-R). Behav Sci Law. 2015 Jun; 33(2-3):199-212.
    View in: PubMed
    Score: 0.090
  3. Swanson JW, Swartz MS, Van Dorn RA, Elbogen EB, Wagner HR, Rosenheck RA, Stroup TS, McEvoy JP, Lieberman JA. A national study of violent behavior in persons with schizophrenia. Arch Gen Psychiatry. 2006 May; 63(5):490-9.
    View in: PubMed
    Score: 0.049
  4. Swanson JW, Swartz MS, Essock SM, Osher FC, Wagner HR, Goodman LA, Rosenberg SD, Meador KG. The social-environmental context of violent behavior in persons treated for severe mental illness. Am J Public Health. 2002 Sep; 92(9):1523-31.
    View in: PubMed
    Score: 0.038
  5. Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, Reimherr F, Miller DD, McGee M, Khan A, Canive JM, Davis SM, Hsiao JK, Lieberman JA. The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study. Schizophr Res. 2008 Mar; 100(1-3):39-52.
    View in: PubMed
    Score: 0.014
  6. Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, Canive JM, Miller DD, Reimherr F, McGee M, Khan A, Van Dorn R, Rosenheck RA, Lieberman JA. Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study. J Nerv Ment Dis. 2006 Mar; 194(3):164-72.
    View in: PubMed
    Score: 0.012
  7. Elbogen EB, Swanson JW, Swartz MS, Van Dorn R. Medication nonadherence and substance abuse in psychotic disorders: impact of depressive symptoms and social stability. J Nerv Ment Dis. 2005 Oct; 193(10):673-9.
    View in: PubMed
    Score: 0.012
  8. Van Dorn RA, Swanson JW, Swartz MS, Elbogen EB. The effects of race and criminal justice involvement on access to atypical antipsychotic medications among persons with schizophrenia. Ment Health Serv Res. 2005 Jun; 7(2):123-34.
    View in: PubMed
    Score: 0.011
  9. Rosenberg SD, Swanson JW, Wolford GL, Osher FC, Swartz MS, Essock SM, Butterfield MI, Marsh BJ. The five-site health and risk study of blood-borne infections among persons with severe mental illness. Psychiatr Serv. 2003 Jun; 54(6):827-35.
    View in: PubMed
    Score: 0.010
  10. Butterfield MI, Bosworth HB, Meador KG, Stechuchak KM, Essock SM, Osher FC, Goodman LA, Swanson JW, Bastian LA, Horner RD. Gender differences in hepatitis C infection and risks among persons with severe mental illness. Psychiatr Serv. 2003 Jun; 54(6):848-53.
    View in: PubMed
    Score: 0.010
  11. Swartz MS, Swanson JW, Hannon MJ, Bosworth HS, Osher FC, Essock SM, Rosenberg SD. Regular sources of medical care among persons with severe mental illness at risk of hepatitis C infection. Psychiatr Serv. 2003 Jun; 54(6):854-9.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.